| 000 | 01894 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517134545.0 | ||
| 264 | 0 | _c20170523 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1420-3049 | ||
| 024 | 7 |
_a10.3390/molecules22010182 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSzekalska, Marta | |
| 245 | 0 | 0 |
_aThe Influence of Chitosan Cross-linking on the Properties of Alginate Microparticles with Metformin Hydrochloride-In Vitro and In Vivo Evaluation. _h[electronic resource] |
| 260 |
_bMolecules (Basel, Switzerland) _cJan 2017 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlginates _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 |
_aChemistry, Pharmaceutical _xmethods |
| 650 | 0 | 4 |
_aChitosan _xchemistry |
| 650 | 0 | 4 |
_aCross-Linking Reagents _xchemistry |
| 650 | 0 | 4 |
_aDelayed-Action Preparations _xchemical synthesis |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xchemically induced |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xchemically induced |
| 650 | 0 | 4 | _aDiet, High-Fat |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDrug Carriers _xchemical synthesis |
| 650 | 0 | 4 |
_aDrug Compounding _xmethods |
| 650 | 0 | 4 |
_aGlucuronic Acid _xchemistry |
| 650 | 0 | 4 |
_aHexuronic Acids _xchemistry |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xchemistry |
| 650 | 0 | 4 |
_aPancreas _xdrug effects |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aStreptozocin |
| 700 | 1 | _aSosnowska, Katarzyna | |
| 700 | 1 | _aZakrzeska, Agnieszka | |
| 700 | 1 | _aKasacka, Irena | |
| 700 | 1 | _aLewandowska, Alicja | |
| 700 | 1 | _aWinnicka, Katarzyna | |
| 773 | 0 |
_tMolecules (Basel, Switzerland) _gvol. 22 _gno. 1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/molecules22010182 _zAvailable from publisher's website |
| 999 |
_c26813536 _d26813536 |
||